G P Bodey|J Nance - JoVE Visualize

Showing results (471-480 of 574) with videos related to

Pageof 58

Sort By:

Journal of Clinical Pharmacology|February 1, 1981

Clinical pharmacology of intramuscularly administered L-asparaginaseD H Ho, H Y Yap, N Brown, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1984

The natural history of gastric cancer and prognostic factors influencing survivalA Y Bedikian, T T Chen, N Khankhanian, et al.

Cancer|January 1, 1977

Bis chloroethyl nitrosourea, vincristine, dimethyl triazeno imidazole carboxamide and chlorpromazine combination chemotherapy in disseminated malignant melanomaE M McKelvey, J K Luce, V K Vaitkevicius, et al.

American Journal of Clinical Oncology|February 1, 1983

Phase II clinical evaluation of intravenous 4'-(9-acridinylamino)methanesulfon-m-anisidide in colorectal cancerM Valdivieso, J R Stroehlein, A Y Bedikian, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 25, 2001

Risk Factors for Candida tropicalis fungemia in patients with cancerD P Kontoyiannis, I Vaziri, H A Hanna, et al.

Lancet (London, England)|August 28, 1976

Detection of Serratia outbreaks in hospitalJ J Farmer, B R Davis, F W Hickman, et al.

Cancer Research|November 1, 1978

Phase 1 clinical investigation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992), a new acridine derivativeS S Legha, J U Gutterman, S W Hall, et al.

Cancer|April 1, 1981

Effect of schedule on activity and toxicity of 5-azacytidine in acute leukemia: a Southwest Oncology Group StudyJ H Saiki, G P Bodey, J S Hewlett, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1978

Clinical, toxicological, and pharmacological studies of combination chemotherapy of adenocarcinoma with adriamycin and Baker's antifolateS W Hall, T F Tenczynski, R S Benjamin, et al.

Journal of Neuro-Oncology|January 1, 1983

A phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumorsL G Feun, D J Stewart, M E Leavens, et al.

Pageof 58

Showing results (471-480 of 574) with videos related to

Sort By:

Pageof 58

Journal of Clinical Pharmacology|February 1, 1981

Clinical pharmacology of intramuscularly administered L-asparaginaseD H Ho, H Y Yap, N Brown, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1984

The natural history of gastric cancer and prognostic factors influencing survivalA Y Bedikian, T T Chen, N Khankhanian, et al.

Cancer|January 1, 1977

Bis chloroethyl nitrosourea, vincristine, dimethyl triazeno imidazole carboxamide and chlorpromazine combination chemotherapy in disseminated malignant melanomaE M McKelvey, J K Luce, V K Vaitkevicius, et al.

American Journal of Clinical Oncology|February 1, 1983

Phase II clinical evaluation of intravenous 4'-(9-acridinylamino)methanesulfon-m-anisidide in colorectal cancerM Valdivieso, J R Stroehlein, A Y Bedikian, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 25, 2001

Risk Factors for Candida tropicalis fungemia in patients with cancerD P Kontoyiannis, I Vaziri, H A Hanna, et al.

Lancet (London, England)|August 28, 1976

Detection of Serratia outbreaks in hospitalJ J Farmer, B R Davis, F W Hickman, et al.

Cancer Research|November 1, 1978

Phase 1 clinical investigation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992), a new acridine derivativeS S Legha, J U Gutterman, S W Hall, et al.

Cancer|April 1, 1981

Effect of schedule on activity and toxicity of 5-azacytidine in acute leukemia: a Southwest Oncology Group StudyJ H Saiki, G P Bodey, J S Hewlett, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1978

Clinical, toxicological, and pharmacological studies of combination chemotherapy of adenocarcinoma with adriamycin and Baker's antifolateS W Hall, T F Tenczynski, R S Benjamin, et al.

Journal of Neuro-Oncology|January 1, 1983

A phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumorsL G Feun, D J Stewart, M E Leavens, et al.

Pageof 58